VOC stands for vaso-occlusive crisis, the most common and painful complication of sickle cell disease. It happens when misshapen red blood cells clump together and block small blood vessels, cutting off blood flow to surrounding tissue. VOCs are the leading reason people with sickle cell disease end up in the emergency room, and they can range from mild episodes managed at home to severe events requiring hospitalization.
How a VOC Happens Inside the Body
In sickle cell disease, red blood cells contain an abnormal form of hemoglobin called hemoglobin S. When these cells pass through tissues that are using a lot of oxygen, the hemoglobin S molecules lose their oxygen and change shape. The altered molecules stick to each other and form long, stiff fibers inside the cell. Those fibers stretch the normally soft, flexible red blood cell into a rigid, sickle-shaped disc that can no longer squeeze through tiny blood vessels.
But the blockage isn’t purely mechanical. The sickling process also damages the outer membrane of the red blood cell, exposing sticky surface proteins that don’t normally appear on healthy cells. These proteins latch onto the walls of blood vessels and onto white blood cells, creating a growing traffic jam in the smallest capillaries and the veins just downstream. The bone marrow, working overtime to replace destroyed red blood cells, releases immature cells that are themselves unusually sticky, adding to the problem. The result is a cascade: sickled cells slow down, stick to the vessel wall, recruit more cells, and eventually choke off blood flow entirely. The tissue beyond the blockage loses its oxygen supply, producing intense pain and, if prolonged, tissue damage.
What a VOC Feels Like
The hallmark of a vaso-occlusive crisis is deep, throbbing pain that can strike almost anywhere in the body. The most common locations are the lower back, knees, shins, and hips, which hurt on more than a third of all pain days in large patient surveys. Pain in the arms, shoulders, upper back, sternum, and chest is less frequent day to day but substantially raises the odds that a person is experiencing a full-blown crisis rather than baseline chronic pain. On crisis days, people typically report pain in more locations at once, averaging about four separate sites compared to three on non-crisis pain days.
The pain often builds over hours, peaks in intensity, and can last anywhere from a few hours to over a week. Many people describe it as a deep ache or pressure that doesn’t respond well to over-the-counter painkillers alone. Crisis episodes vary enormously from person to person and even from one episode to the next in the same person.
How Often VOCs Occur
The frequency of crises varies widely. A large international survey of people 16 and older with sickle cell disease found a median of 3 crises per year, though the average was higher at 5.2 per year because some patients experience far more. Among U.S. patients specifically, the average was 7.1 crises per year. Studies that tracked home-managed episodes through daily pain diaries, not just hospital visits, found even higher numbers ranging from 5.2 to 13.6 per year. That gap highlights how many crises people ride out at home without ever showing up in hospital data.
Common Triggers
VOCs don’t always strike randomly. Several environmental and physical factors speed up the sickling process by changing oxygen levels, blood flow, or hydration inside red blood cells:
- Cold weather or wind: Most studies link cold exposure to increased hospital visits for pain. Many patients report that pain starts within hours of getting cold, likely because blood vessels constrict and slow flow through the smallest capillaries.
- Dehydration: When red blood cells lose water, the hemoglobin S inside becomes more concentrated and polymerizes faster. Not drinking enough fluids, especially in heat, is one of the most preventable triggers.
- Infection: Illness increases inflammation and oxygen demand, both of which promote sickling. Seasonal infection patterns may partly explain why crises cluster in certain months.
- Intense exercise: Physical exertion drives up lactic acid, lowers tissue oxygen, and causes fluid loss, all of which tilt conditions toward sickling.
- Extreme heat: While cold gets more attention, very hot weather can also precipitate crises, likely through dehydration and changes in blood flow.
Cumulative Damage From Repeated Crises
Each VOC is painful on its own, but the real danger lies in the accumulation of blocked blood flow over years. Repeated episodes of oxygen deprivation cause progressive, often irreversible organ damage. Joints, especially the hips and shoulders, can develop osteonecrosis, where bone tissue dies and collapses, leading to chronic arthritis. The kidneys gradually lose filtering capacity and can progress to chronic kidney failure. The eyes develop a form of retinopathy from damaged blood vessels in the retina. The brain is at increased risk for stroke, both obvious large strokes and silent strokes that chip away at cognitive function over time.
When a Crisis Becomes an Emergency
About 3% of patients hospitalized for an uncomplicated VOC go on to develop acute chest syndrome, the most dangerous acute complication of sickle cell disease. Acute chest syndrome occurs when sickling and inflammation affect the lungs, and it can escalate quickly. Warning signs include fever at or above 100.4°F, a new cough, shortness of breath, fast and shallow breathing, wheezing, and chest pain (particularly in adults). Low blood oxygen is a key feature. Without prompt treatment, acute chest syndrome can lead to respiratory failure, kidney injury, and multi-organ failure.
Any VOC accompanied by these respiratory symptoms, altered mental status, or sudden worsening of pain despite treatment needs immediate medical attention.
How VOCs Are Diagnosed
There is no single test that confirms a VOC. Diagnosis is primarily clinical, based on the patient’s history and the character and location of their pain. Doctors do use blood work to gauge severity and track progression. Hemoglobin levels and reticulocyte counts (a measure of how fast the bone marrow is producing new red blood cells) are checked together. Early in a crisis, hemoglobin drops while reticulocyte counts rise as the body tries to compensate. If the crisis drags on, the bone marrow can become exhausted, and reticulocyte counts fall too, signaling more severe anemia and a need for closer monitoring.
Markers of red blood cell destruction, including LDH and unconjugated bilirubin, typically rise during a crisis and reflect the degree of hemolysis. However, none of these markers are specific to VOC. Elevated LDH, for example, can come from many conditions, so doctors interpret these values alongside the clinical picture rather than relying on any single number.
Treating Acute Pain
Pain control is the immediate priority during a VOC. The American Society of Hematology recommends that patients arriving at an emergency department be assessed and given pain relief within one hour, with reassessments every 30 to 60 minutes until pain is under control. For mild crises, a short course of anti-inflammatory medications like ibuprofen or naproxen, typically lasting 5 to 7 days, may be sufficient. For more severe pain, opioid therapy is standard, with dosing tailored to what the patient normally takes and what has worked for them in past episodes. Hydration, either by drinking fluids or receiving them intravenously, helps counteract one of the key drivers of sickling.
Reducing How Often Crises Happen
Several therapies aim to prevent VOCs rather than just treat them. Hydroxyurea remains the most established option. It works by boosting production of fetal hemoglobin, a form of hemoglobin that interferes with the sickling process. L-glutamine, an amino acid supplement approved for sickle cell disease, reduced the number of crises by about 25% over 48 weeks in clinical trials, bringing the median annual count from 4 down to 3.
Crizanlizumab, a medication given by infusion that blocks sticky interactions between blood cells and vessel walls, showed a 45% reduction in annual crisis rate in its initial phase 2 trial, dropping the median from 3 to 1.6 per year. However, a larger phase 3 trial failed to confirm a significant difference over placebo, leaving its role less certain. Voxelotor takes a different approach by preventing hemoglobin S from releasing oxygen too readily, which keeps red blood cells in a more normal shape. It significantly improves hemoglobin levels and reduces markers of red blood cell destruction, though its direct effect on crisis frequency is less clearly established.
Beyond medications, practical prevention matters. Staying well hydrated, dressing warmly in cold weather, avoiding sudden temperature changes, managing infections early, and pacing physical activity all help reduce the conditions that trigger sickling.